Related Experiment Video
Updated: Dec 11, 2025

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
Published on: October 12, 2018
Designed protein logic to target cells with precise combinations of surface antigens
Marc J Lajoie1,2, Scott E Boyken3,2, Alexander I Salter4,5
1Institute for Protein Design, University of Washington, Seattle, WA, USA. mlajoie@lyell.com dabaker@uw.edu.
Abstract:
Precise cell targeting is challenging because most mammalian cell types lack a single surface marker that distinguishes them from other cells. A solution would be to target cells using specific combinations of proteins present on their surfaces. In this study, we design colocalization-dependent protein switches (Co-LOCKR) that perform AND, OR, and NOT Boolean logic operations. These switches activate through a conformational change only when all conditions are met, generating rapid, transcription-independent responses at single-cell resolution within complex cell populations. We implement AND gates to redirect T cell specificity against tumor cells expressing two surface antigens while avoiding off-target recognition of single-antigen cells, and three-input switches that add NOT or OR logic to avoid or include cells expressing a third antigen. Thus, de novo designed proteins can perform computations on the surface of cells, integrating multiple distinct binding interactions into a single output.
Insights
Researchers developed colocalization-dependent protein switches (Co-LOCKR) for precise cell targeting. These engineered proteins perform Boolean logic operations, enabling AND, OR, and NOT functions for advanced cellular computation and targeted therapies.
Area of Science:
- Biochemistry
- Synthetic Biology
- Immunology
Background:
- Mammalian cell identification is complex due to the lack of unique surface markers.
- Targeting specific cell populations requires methods beyond single-marker recognition.
Purpose of the Study:
- To design novel protein-based switches capable of performing Boolean logic operations (AND, OR, NOT).
- To enable precise, transcription-independent cellular responses at single-cell resolution within complex biological systems.
- To demonstrate the application of these switches in redirecting T cell specificity for targeted cancer therapy.
Main Methods:
- Design and engineering of colocalization-dependent protein switches (Co-LOCKR).
- Implementation of Co-LOCKR systems to perform AND, OR, and NOT logic gates.
- Application of Co-LOCKR for T cell redirection against tumor cells with specific surface antigen combinations.
Main Results:
- Co-LOCKR switches successfully executed AND, OR, and NOT Boolean logic operations.
- Engineered AND gates enabled T cell targeting of tumor cells expressing dual antigens while avoiding single-antigen cells.
- Three-input switches integrated NOT or OR logic to refine cellular targeting based on additional antigen presence.
Conclusions:
- De novo designed proteins can perform computational logic on cellular surfaces.
- Co-LOCKR technology offers a versatile platform for precise cell targeting and therapeutic applications.
- This approach allows for sophisticated integration of multiple binding events into a single, functional output.
Related Concept Videos
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Targeted Cancer Therapies
There are several types of targeted therapies against...

